Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

Effects of the Butanol Extact of Head of Panax Ginseng on Type II Collagen-induced Arthritis in DBA/1J Mice

  • Published : 2007.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

In order to evaluate the improvement effects of head of Panax ginseng on chronic arthritis, we have investigated the activity of butanol fraction (BuOH fraction) in vitro and in vivo system. BuOH fraction showed significant inhibition on the elastase activity. Anti-arthritic activity of BuOH fraction was also examined on type II collagen-induced arthritis in DBA/1J mice. Mice were immunized with injection of type II collagen emulsified in Freund's complete adjuvant, followed by a booster injection 21 days later. BuOH fraction(BHPG) was administered at an oral dose of 500mg/kg for 2 weeks from the 1st day boost. The hind paw edema was significantly decreased in the group of treatment with BuOH fraction compared to control. In collagen-induced DBA/1J mice, BuOH fraction did not affected the collagen antibody titer but significantly inhibited the tumor necrosis factoralpha(TNF-${\alpha}$) activity. These results were confirmed with histological evaluation of joint tissues. This study may raise the possibility that the usage of BuOH fraction of head of Panax ginseng as alternative medicine for the relief and prevention of rheumatoid arthritis symptoms.

Keywords

References

  1. Grassi, W., Angelis, R. D., Lamanna, G. and Cervini, C. (1998). The clinical features of rheumatoid arthritis. Eur. J. Radiol. 27, S18-S24 https://doi.org/10.1016/S0720-048X(98)00038-2
  2. Bondeson, J.(1997). The mechanisms of action of disease-modifying antirheumatic drugs: a review with emphasis on macrophage signal transduction and the induction of proinflammatory cytokines. Gen. Pharmacol. 29, 127-50 https://doi.org/10.1016/S0306-3623(96)00419-3
  3. Madhok, R., Crilly, A., Watson, J. and Capell, H.A. (1993). Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity. Ann Rheum Dis. 52, 232-4 https://doi.org/10.1136/ard.52.3.232
  4. Terato, K., Ye, X.J., Miyahara, H., crème, M.A. and Griffiths, M.M. (1996). Induction by chronic autoimmune arthritis in DBA/1 mice by oral administration of type II collagen and Escherichia coli lipopolysaccharide. Br. J. Rheumatol. 35, 828-38 https://doi.org/10.1093/rheumatology/35.9.828
  5. Corthay, A., Johansson, A., Vestberg, M. and Holmdahl, R. (1999). Collagen-induced arthritis development requires alpha beta T cells but not gamma delta T cells: studies with T celldeficient (TCR mutant) mice. Int. Immunol. 11, 1065-73 https://doi.org/10.1093/intimm/11.7.1065
  6. Holmdahl, M., Vestberg, M. and Holmdahl, R.(2002). Primed B cells present type-II collagen to T cells. Scand. J. Immunol. 55, 382-9 https://doi.org/10.1046/j.1365-3083.2002.01071.x
  7. Probert, L., Keffer, J., Corbella, P., Cazlaris, H., Patsavoudi, E., Stephens, S., Kaslaris, E., Kioussis, D. and Kollias, G.(1993) Wasting, ischemia, and lymphoid abnormalities in mice expressing T cell-targeted human tumor necrosis factor transgenes. J. Immunol. 151, 1894-906
  8. Hom, J.T., Butler, L.D., Riedl, P.E. and Bendele, A.M.(1988). The progression of the inflammation in established collageninduced arthritis can be altered by treatments with immunological or pharmacological agents which inhibit T cell activities. Eur. J. Immunol. 18, 881-8 https://doi.org/10.1002/eji.1830180608
  9. Volpi, N.(1996). Inhibition of human leukocyte elastase activity by heparins: influence of charge density. Biochim. Biophys. Acta. 1290, 299-307 https://doi.org/10.1016/0304-4165(96)00033-5
  10. Omata, T., Itokazu, Y., Inoue, N. and Segawa, Y. (2000). Effects of chondroitin sulfate-C on articular cartilage destruction in murine collagen-induced arthritis. Arzneimittel forschung. 50, 148-53
  11. Fujie, K., Shinguh, Y., Inamura, N., Yasumitsu, R., Okamoto, M. and Okuhara, M.(1999). Release of neutrophil elastase and its role in tissue injury in acute inflammation: effect of the elastase inhibitor, FR134043. Eur. J. Pharmacol. 374, 117-25 https://doi.org/10.1016/S0014-2999(99)00268-X
  12. Cague, R.B., Firth, S.A., Holt, P.J., Skingle, J., Geenbury, C.L. and Webley, M.. (1983). Serum antibodies to type II collagen in rheumatoid arthritis: comparison of 6 immunological methods and clinical features. Ann. Rheum. Dis. 42, 537-44 https://doi.org/10.1136/ard.42.5.537
  13. Chu, C.Q., Field, M., Feldmann, M. and Maini, R.N. (1991). Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum. 34, 1125-32 https://doi.org/10.1002/art.1780340908
  14. Chu, C.S., Trapnell, B.C., Curristin, S.M., Cutting, G.R. and Crystal, R.G.(1992). Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis. J. Clin. Invest. 90, 785-90 https://doi.org/10.1172/JCI115952
  15. Marinova-Mutafchieva, L., Williams, R.O., Mason, L. J., Mauri, C., Feldmann, M. and Maini, R.N.(1997). Dynamics of proinflammatory cytokine expression in the joints of mice with collagen- induced arthritis (CIA). Clin. Exp. Immunol. 107, 507-12 https://doi.org/10.1046/j.1365-2249.1997.2901181.x
  16. Arend, W.P. and Dayer, J.M.(1990). Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum. 33, 305-15 https://doi.org/10.1002/art.1780330302